The largest database of trusted experimental protocols

16 protocols using precision glide

1

Screening for HBV and CD4+ T-Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples were obtained from each patient and used for screening for HBV serological markers as well as for performing cluster of differentiation CD4+ T-lymphocyte enumeration and clinical chemistry analysis of alanine aminotransferase (ALT). The process involved collection of blood using a BD Precision Glide™ into a 4 mL EDTA BD Vacutainer® (Becton Dickinson, Plymouth, United Kingdom) for CD4+ T-lymphocyte enumeration and into a 6 mL BD Vacutainer® Clot Activator Tube (Becton Dickinson, Plymouth, United Kingdom).
+ Open protocol
+ Expand
2

Intrastromal Injection in Cornea

Check if the same lab product or an alternative is used in the 5 most similar protocols
In preparation for the intrastromal injection, mice were provided with carprofen gel packs 24 hours before the procedure. Mice were anesthetized by intraperitoneal injection of ketamine hydrochloride (80 mg/kg) and xylazine (10 mg/kg). The intrastromal injection was carried out as previously described.25 (link) Briefly, a small slit was made in the anterior stroma in the mid-periphery of the cornea with a 27G beveled needle (Monoject, 27G × 1/2”; BD Precisionglide, Becton Dickinson and Co., Franklin Lakes, NJ, USA).
Thereafter, the needle tip was moved sideways to create a small stromal pocket. A blunt 27G needle attached to a 10 μL syringe (Hamilton) was used to inject 2 μL of 0.2% LMWHA, 0.2% HMWHA or PBS (vehicle control) into the corneal stroma of HAS2Δ/ΔCorEpi mice. The success of the intrastromal injection was monitored by verifying transient opacity in the central cornea immediately after the injection. The procedure was carried out under a ZEISS stemi 508 microscope in sterile conditions. The lymphatic vessel branches were then counted by two independent investigators in a blinded manner. At least six corneas were analyzed for each experimental point.
+ Open protocol
+ Expand
3

Probenecid and Tonabersat Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treatment consisted of a final predicted blood circulating concentration of 1 mM probenecid, or a combination of both 1 mM probenecid and 30 µM tonabersat (prepared as outlined below in 2.3); the control consisted of a similar volume of 0.9% NaCl (saline) injection. Animals were treated twice by an intraperitoneal (i.p.) injection 2 h after the onset and immediately after the completion of the 24 h light exposure. All i.p. injections were conducted using a syringe attached to a 27 G x ½ inch needle (BD PrecisionGlide™, Becton-Dickinson and Co., Franklin Lakes, NJ, USA). Tonabersat and probenecid solutions were i.p. injected consecutively, as combining both drugs while concentrated caused drug precipitation.
No anesthesia was applied during i.p. drug administration and animals were restrained by the over the shoulder grip technique [51 (link)]. All other manipulations were performed on anaesthetized rats using a combination of ketamine (75 mg/kg, Parnell Laboratories, Auckland, New Zealand) and domitor (0.5 mg/kg, Pfizer, Auckland, New Zealand) in saline. Following manipulations, anesthesia was reversed by i.p. injection of atipamezole (1 mg/kg antisedan, Pfizer) and the animals were returned to their cages and monitored during anesthesia recovery.
+ Open protocol
+ Expand
4

Purification of Insect-Derived Biomaterials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately the same number of S. bullata pupae were collected as described above. Pupae were subsequently rinsed in sterile millipore water to remove small particulates. They were then crushed by hand through a 100 µm nylon net (EMD Millipore, Merck Millipore, Billerica, MA, USA) and the filtrate was collected in a sterile 250 ml glass beaker. Nylon powder-free non-sterile gloves were worn during this extraction. The filtrate was centrifuged at 4 °C (25,000xG) for 10 min to separate the sediment, protein, and lipid layers. Using a 22 gauge needle (BD PrecisionGlide; Becton, Dickinson and Company, Franklin Lakes, NJ), the protein layer was transferred to a sterile beaker. Schneider’s Drosophila media was added to the protein extract to triple the volume and, using a reusable vacuum filtration apparatus (Nalgene; Thermo Fisher scientific Incorporated, Waltham, MA, USA), the resulting mixture was passed through filters with gradually smaller pore sizes (11, 6, 2.5, 0.8, and 0.45 µm). A 0.22 µm syringe filter (Costar; Corning Incorporated, Corning, NY, USA) was used to remove bacteria. The final product was stored at 4 °C until use (Fig. 1). The following is a step-wise protocol for the production of NRMv2.
+ Open protocol
+ Expand
5

Measuring Portal Pressure in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six rats in the sham group and 10 rats in each of the other groups (n = 40) were used to measure portal pressure. Portal pressure was measured at 10, 30, and 60 minutes postoperatively in subgroup M6 and at 24 hours postoperatively in subgroup M24. Portal pressure was measured by direct puncture of the portal vein using a 26-G needle (BD Precisionglide, Becton Dickinson, Franklin Lakes, NJ, USA) with an invasive intravascular pressure monitoring device (Vigileo Monitor, Edwards Lifesciences, Irvine, CA, USA).
+ Open protocol
+ Expand
6

Purification of Acinetobacter Baumannii Phage

Check if the same lab product or an alternative is used in the 5 most similar protocols
A culture of A. baumannii strain 6077/12 was grown to mid-exponential phase in a volume of 500 mL and was infected with 1 mL of previously obtained phage suspension [titer 109 plaque forming units (PFUs)/mL]. After overnight incubation, the lysate was centrifuged in Sorvall RC3B centrifuge at 13,689.2 × g for 30 min in rotor GS3 to pellet bacterial debris. The supernatant was collected and treated with DNaseI and RNase A (Thermo Fisher) for 2 h at 37°C. Afterward, NaCl and polyethylene glycol (PEG 8000; Sigma) were added (to obtain 1 M and 10% final concentrations, respectively), stirred, and incubated overnight at +4°C to precipitate the phages. The precipitate was centrifuged at 13,689.2 × g for 30 min at +4°C (Sorvall RC3B centrifuge, rotor GS3), and the pellet was resuspended in 4 mL of SM buffer. CsCl was added to reach 0.75 g/mL density. The samples were ultracentrifuged at 131,980.8 × g for 24 h in Beckman Coulter Optima L-80 XP ultracentrifuge in rotor SW55 Ti, after which the distinct phage-containing bluish band was visible at the midpoint of the tube. The phages were extracted from tube by using a 22-gauge needle (PrecisionGlide™; Becton Dickinson, Dubline, Ireland) and dialyzed overnight against 2 L of SM buffer at +4°C. Purified phages were filtered through 0.22-μm filters (Filtropur S 0.45; Sarstedt) and used in subsequent experiments.
+ Open protocol
+ Expand
7

Electrospun Silk Fibroin Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
To create the solution, 5% of 5 and 20 UMF MH were, separately, dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP, Oakwood Chemical) through a 20-minute sonication in a RT water bath (Branson 200 Ultrasonic Cleaner, Branson Ultrasonics). Lyophilized SF (5%) was then dissolved overnight in the MH-containing solution using a mechanical shaker. The solution was loaded into a 5 mL syringe tipped with a blunted 18-gauge needle (PrecisionGlide, Becton Dickinson). Electrospinning was completed using a syringe pump (78-01001, Fisher Scientific) set at 3 mL/hr. A high-voltage DC power supply (CZE1000PN30, Spellman High Voltage Electronics Corp.) provided a voltage of 23 kV onto a spinning (400 rpm) rectangular (0.5 cm × 2.5 cm × 9 cm) stainless steel mandrel using a working distance of 16.5 cm. All ES scaffolds were removed from the mandrel and stored at −20°C in a desiccation chamber. Three of each ES scaffold were used for all characterization and testing.
+ Open protocol
+ Expand
8

Electrospun Silk Fibroin Scaffolds with Manuka Honey

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five percent SF electrospun (ES) scaffolds were fabricated, with and without 5% MH. For the ES scaffolds that included honey, 5% MH (Manuka Honey, Medical Grade 12+, Ndal Laboratories, Monterey, CA, USA) was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP, Oakwood Chemical, West Columbia, SC, USA) using a 20 min water bath sonication (Branson 200 Ultrasonic Cleaner, Branson Ultrasonics, St. Louis MO, USA). Following dissolution, 5% lyophilized SF was placed in the solution and allowed to dissolve overnight under mechanical agitation. The following day, the solution was loaded in a 5 mL syringe fixed with a blunt-tipped 18 gauge needle (PrecisionGlide, Becton Dickinson, Franklin Lakes, NJ, USA). The solution was then electrospun under the following parameters: voltage of 23 kV, working distance of 16.5 cm, and extrusion rate of 3 mL/h. The fibers were collected on a translating, rotating (400 rpm) rectangular (0.5 cm × 2.5 cm × 9 cm) stainless steel mandrel. Following removal, all ES scaffolds were crosslinked using methanol vapor and stored at room temperature (RT) in a desiccation chamber. Note that for the ES scaffolds that did not include honey, the initial sonication step was excluded from the solution preparation.
+ Open protocol
+ Expand
9

NIH 3T3 Wound Healing Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIH 3T3 cells were grown to confluence following the appropriate treatment, wounded with a 0.8-mm needle (PrecisionGlide, Becton Dickinson, Franklin Lakes, NJ), and washed twice with PBS before the addition of new medium. Subsequent fixation/immunostaining or live-cell imaging was performed 5 h after wounding.
+ Open protocol
+ Expand
10

Serum Cortisol and Haptoglobin Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum cortisol and haptoglobin concentrations were measured from 4-mL blood samples collected by venipuncture from both jugular veins immediately before treatment; at 15, 30, 60, and 120 min; and at 6 and 24 h following treatment. Each kid was firmly restrained by a handler while samples were collected using 22-G, 2.54-cm needles (PrecisionGlide, Becton Dickinson, Franklin Lakes, NJ) and kept in serum tubes (Becton Dickinson). Blood samples were centrifuged at approximately 1,500 × g for 10 min at 20°C after leaving the samples to sit for approximately 1.5 h. The serum was separated and stored at -20°C until analyzed.
Samples were analyzed by a commercial laboratory using standard quality control methodologies; technicians were blind to the treatment each kid received. Cortisol concentrations were determined by electrochemiluminescence immunoassay using a commercial kit (Roche Diagnostics GmbH, Mannheim, Germany). Sensitivity of the assay was 1.5 nmol/L. Haptoglobin concentrations were determined by colorimetric assay using a Tridelta phase haptoglobin kit (Tridelta Development Ltd., Maynooth, Ireland) . Sensitivity of the assay was 0.005 mg/mL.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!